ELV
Elevance Health, Inc.
Overview
Elevance Health, Inc is a Healthcare company operating in Healthcare Plans with a $84.37B market cap.
Most recent reported earnings: Q2 FY2026 (Jul 15, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-04-2217 Q&A exchanges
- Q4 FY2025Earnings2026-01-2816 Q&A exchanges
- Q3 FY2025Earnings2025-10-2115 Q&A exchanges
- Q2 FY2025Earnings2025-07-1719 Q&A exchanges
- Q1 FY2025Earnings2025-04-2216 Q&A exchanges
- Q4 FY2024Earnings2025-01-2316 Q&A exchanges
- Q3 FY2024Earnings2024-10-1718 Q&A exchanges
- Q2 FY2024Earnings2024-07-1719 Q&A exchanges
- Q1 FY2024Earnings2024-04-1818 Q&A exchanges
- Q4 FY2023Earnings2024-01-2414 Q&A exchanges
- Q3 FY2023Earnings2023-10-1810 Q&A exchanges
- Q2 FY2023Earnings2023-07-1911 Q&A exchanges
- Q1 FY2023Earnings2023-04-1913 Q&A exchanges
- Q4 FY2022Earnings2023-01-2516 Q&A exchanges
- Q3 FY2022Earnings2022-10-1913 Q&A exchanges
- Q2 FY2022Earnings2022-07-2019 Q&A exchanges
- Q1 FY2022Earnings2022-04-2017 Q&A exchanges
- Q4 FY2021Earnings2022-01-2618 Q&A exchanges
- Q3 FY2021Earnings2021-10-2019 Q&A exchanges
- Q2 FY2021Earnings2021-07-2115 Q&A exchanges
- Q1 FY2021Earnings2021-04-2116 Q&A exchanges
History
Earnings history
- Q2 FY20262026-07-15EPS— vs $6.20—Rev— vs ——EODHD
- Q1 FY20262026-04-21EPS$12.58 vs $10.81+16.4%Rev$50.18B vs ——EODHD
- Q4 FY20252026-01-27EPS$3.33 vs $3.09+7.8%Rev$49.75B vs ——EODHD
- Q3 FY20252025-10-20EPS$6.03 vs $4.94+22.1%Rev$50.71B vs ——EODHD
- Q2 FY20252025-07-16EPS$8.84 vs $8.92-0.9%Rev$49.78B vs ——EODHD
- Q1 FY20252025-04-21EPS$11.97 vs $11.48+4.3%Rev$48.89B vs ——EODHD
- Q4 FY20242025-01-22EPS$3.84 vs $3.85-0.3%Rev$45.44B vs ——EODHD
- Q3 FY20242024-10-16EPS$8.37 vs $9.65-13.3%Rev$45.15B vs ——EODHD
- Q2 FY20242024-07-16EPS$10.12 vs $10.01+1.1%Rev$43.65B vs ——EODHD
- Q1 FY20242024-04-17EPS$10.64 vs $10.53+1.0%Rev$42.58B vs ——EODHD
- Q4 FY20232024-01-23EPS$5.62 vs $5.59+0.5%Rev$42.65B vs ——EODHD
- Q3 FY20232023-10-17EPS$8.99 vs $8.46+6.3%Rev$42.85B vs ——EODHD
- Q2 FY20232023-07-18EPS$9.04 vs $8.78+3.0%Rev$43.67B vs ——EODHD
- Q1 FY20232023-04-18EPS$9.46 vs $9.28+1.9%Rev$42.17B vs ——EODHD
- Q4 FY20222023-01-24EPS$5.23 vs $5.19+0.8%Rev$38.99B vs ——EODHD
- Q3 FY20222022-10-18EPS$7.53 vs $7.15+5.3%Rev$39.94B vs ——EODHD
- Q2 FY20222022-07-19EPS$8.04 vs $7.74+3.9%Rev$38.63B vs ——EODHD
- Q1 FY20222022-04-19EPS$8.25 vs $7.83+5.4%Rev$38.09B vs ——EODHD
- Q4 FY20212022-01-25EPS$5.14 vs $5.12+0.4%Rev$34.88B vs ——EODHD
- Q3 FY20212021-10-19EPS$6.79 vs $6.37+6.6%Rev$35.82B vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-07-15 | — | $6.20 | — | — | — | — | EODHD |
| Q1 FY2026 | 2026-04-21 | $12.58 | $10.81 | +16.4% | $50.18B | — | — | EODHD |
| Q4 FY2025 | 2026-01-27 | $3.33 | $3.09 | +7.8% | $49.75B | — | — | EODHD |
| Q3 FY2025 | 2025-10-20 | $6.03 | $4.94 | +22.1% | $50.71B | — | — | EODHD |
| Q2 FY2025 | 2025-07-16 | $8.84 | $8.92 | -0.9% | $49.78B | — | — | EODHD |
| Q1 FY2025 | 2025-04-21 | $11.97 | $11.48 | +4.3% | $48.89B | — | — | EODHD |
| Q4 FY2024 | 2025-01-22 | $3.84 | $3.85 | -0.3% | $45.44B | — | — | EODHD |
| Q3 FY2024 | 2024-10-16 | $8.37 | $9.65 | -13.3% | $45.15B | — | — | EODHD |
| Q2 FY2024 | 2024-07-16 | $10.12 | $10.01 | +1.1% | $43.65B | — | — | EODHD |
| Q1 FY2024 | 2024-04-17 | $10.64 | $10.53 | +1.0% | $42.58B | — | — | EODHD |
| Q4 FY2023 | 2024-01-23 | $5.62 | $5.59 | +0.5% | $42.65B | — | — | EODHD |
| Q3 FY2023 | 2023-10-17 | $8.99 | $8.46 | +6.3% | $42.85B | — | — | EODHD |
| Q2 FY2023 | 2023-07-18 | $9.04 | $8.78 | +3.0% | $43.67B | — | — | EODHD |
| Q1 FY2023 | 2023-04-18 | $9.46 | $9.28 | +1.9% | $42.17B | — | — | EODHD |
| Q4 FY2022 | 2023-01-24 | $5.23 | $5.19 | +0.8% | $38.99B | — | — | EODHD |
| Q3 FY2022 | 2022-10-18 | $7.53 | $7.15 | +5.3% | $39.94B | — | — | EODHD |
| Q2 FY2022 | 2022-07-19 | $8.04 | $7.74 | +3.9% | $38.63B | — | — | EODHD |
| Q1 FY2022 | 2022-04-19 | $8.25 | $7.83 | +5.4% | $38.09B | — | — | EODHD |
| Q4 FY2021 | 2022-01-25 | $5.14 | $5.12 | +0.4% | $34.88B | — | — | EODHD |
| Q3 FY2021 | 2021-10-19 | $6.79 | $6.37 | +6.6% | $35.82B | — | — | EODHD |
Source: EODHD. ELV reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks ELV's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $2.73 | $2.84 | -3.8% | +1.8% | +1.1% |
| Q4 FY2026 | $2.82 | $2.96 | -4.7% | +0.3% | -0.4% |
| Q3 FY2026 | $2.73 | $2.91 | -6.2% | -3.3% | -3.7% |
| Q2 FY2026 | $2.43 | $2.87 | -15.2% | -1.2% | -3.5% |
| Q1 FY2025 | $2.39 | $2.82 | -15.4% | +3.0% | +3.7% |
| Q4 FY2025 | $2.62 | $2.92 | -10.3% | -7.4% | -8.1% |
| Q3 FY2025 | $2.74 | $2.99 | -8.4% | -5.2% | -2.8% |
| Q2 FY2025 | $2.65 | $2.78 | -4.5% | +2.5% | +3.9% |
| Q1 FY2024 | $2.76 | $3.08 | -10.5% | -1.2% | +1.0% |
| Q4 FY2024 | $2.60 | $3.10 | -16.1% | +0.3% | -2.4% |
Guidance change history
Sample- Q1 FY2026Maintained2026-04-15
- Q4 FY2026Lowered2026-13-15
- Q3 FY2026Lowered2026-10-15
- Q2 FY2026Lowered2026-07-15
- Q1 FY2025Lowered2025-04-15
- Q4 FY2025Lowered2025-13-15
- Q3 FY2025Lowered2025-10-15
- Q2 FY2025Lowered2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Gail BoudreauxCEO11 mo20 callsCurrentSample
CEO since 2025 • 2/4 beats (50%) • last guidance cut Q3 FY2026
- Mark KayeCFO1 yr 2 mo9 callsCurrentSample
CFO since 2025 • 2/4 beats (50%) • guidance suspended Q1 FY2026
- Charles Morgan Kendrick JrPresident1 yr 3 mono recorded callsCurrentSample
PRESIDENT since 2025 • 2/4 beats (50%) • last guidance cut Q3 FY2026
- Ryan R CraigEVP & Chief HR Officer10 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 3/4 beats (75%) • last call held guidance Q3 FY2026
- Erin M WesslingEVP & Chief Legal Officer10 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 3/4 beats (75%) • last guidance raise Q1 FY2026
- Ratnakar LavuEVP & Chief Digital Info Ofr3 mono recorded callsCurrentSample
DIVISION_HEAD since 2026 • 1/2 beats (50%) • last guidance raise Q2 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for ELV.
$ curl https://api.spokenalpha.com/v1/companies/ELVFAQ
Frequently asked about ELV
Where can I find Elevance Health, Inc.'s (ELV) earnings call transcripts?
Spoken Alpha indexes ELV's earnings call transcripts at https://spokenalpha.com/companies/ELV. Each call links to attributed speakers and parsed analyst Q&A. Elevance Health, Inc.'s own investor relations page is at https://ir.elevancehealth.com/investors/default.aspx.
When was Elevance Health, Inc.'s most recent earnings call?
Elevance Health, Inc. (ELV) held its most recent earnings call on 2026-04-22, covering fiscal Q1 2026.
What sector is ELV in?
Elevance Health, Inc. (ELV) operates in the Healthcare sector (Healthcare Plans industry).